Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04743661
Title 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pediatric Brain Tumor Consortium
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital Los Angeles Los Angeles California 90027 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field